On the physiological role of cytosolic 5'-nucleotidase II (cN-II): Pathological and therapeutical implications

Current Medicinal Chemistry

Volumn 20, Issue 34, 2013, Pages 4285-4291

  Tozzi, M G ^a   Pesi, R ^a   Allegrini, S ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

5' nucleotidase; AMP kinase; CN II; Energy charge; Nucleoside phosphotransferase; Protein hyperexpression; Protein silencing

Indexed keywords

5' NUCLEOTIDASE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ADENOSINE 2' PHOSPHATE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE DIPHOSPHATE; ADENOSINE KINASE; ADENOSINE MONOPHOSPHATE DEAMINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; COMPLEMENTARY DNA; GLUTAMINE; GUANOSINE PHOSPHATE; HYBRID PROTEIN; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE; INOSINE PHOSPHATE; MAGNESIUM; NUCLEOTIDASE; PHOSPHATASE; PHOSPHOTRANSFERASE; PURINE; PURINE NUCLEOSIDE; PURINE NUCLEOSIDE PHOSPHORYLASE; PURINE NUCLEOTIDE; PYRIMIDINE; RIBONUCLEOSIDE; UNINDEXED DRUG; URIDINE KINASE;

ALLOSTERISM; ARTICLE; CELL GROWTH; CELL TYPE; COLON CARCINOMA; CONVERGENT EVOLUTION; CYTOSOL; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; LESCH NYHAN SYNDROME; MAMMAL CELL; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERTEBRATE; YEAST;

5'-NUCLEOTIDASE; ANIMALS; CYTOSOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; HUMANS; YEASTS;

EID: 84887932481     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320340007     Document Type: Article

References (57)

1. Bianchi, V.; Spychala, J. Mammalian 5'-nucleotidases, J. Biol. Chem., 2003, 278, 46195-46198.
2. Itoh, R. IMP-GMP 5'-nucleotidase. Comp. Biochem. Physiol. B., 1993, 105, 13-19.
3. Hunsucker, S.A.; Mitchell, B.S.; Spychala, J. The 5'-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther., 2005, 107, 1-30.
4. Spychaa, J.; Madrid-Marina, V.; Fox. I.H. High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. J. Biol. Chem., 1988, 263, 18759-18765.
5. Itoh, R. Purification and some properties of cytosol 5'-nucleotidase from rat liver. Biochim. Biophys. Acta., 1981, 657, 402-410.
6. Pesi, R.; Turriani, M.; Allegrini, S.; Scolozzi, C.; Camici, M.; Ipata, P.L.; and Tozzi, M.G. The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. Arch. Biochem. Biophys., 1994, 312, 75-80.
7. Worku, Y.; Newby, A.C. Nucleoside exchange catalysed by the cytoplasmic 5'-nucleotidase. Biochem. J., 1982, 205, 503-510.
8. Tozzi, M.G.; Camici, M.; Pesi, R.; Allegrini, S.; Sgarrella, F.; Ipata, P.L. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5'-nucleotidase, Arch. Biochem. Biophys., 1991, 291, 212-217.
9. Baiocchi, C.; Pesi, R.; Camici, M.; Itoh, R.; Tozzi, M.G. Mechanism of the reaction catalysed by cytosolic 5'-nucleotidase/ phosphotransferase: formation of a phosphorylated intermediate. Biochem. J., 1996, 317, 797-801.
10. Ipata, P.L. and Tozzi M.G. Recent advances on structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II. Purinergic Signal., 2006, 2, 669-675.
11. Bretonnet, A.S.; Jordheim, L.P.; Dumontet, C.; Lancelin, J.M. Regulation and activity of cytosolic 5' nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism. FEBS Lett., 2005, 579, 3363-3368.
12. Itoh, R.; Yamada, K. Pig lung 5'-nucleotidase: effect of diadenosine 5',5'''-P1, P4-tetraphosphate and its related compounds. Int. J. Biochem., 1990, 22, 231-238.
13. Itoh, R.; Oka, J.. Evidence for existence of a cytosol 5'-nucleotidase in chicken heart: comparison of some properties of heart and liver enzymes. Comp. Biochem. Physiol. B., 1985, 81, 159-163.
14. Traut, T.W. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem., 1994, 140, 1-22.
15. Pinto, R.M.; Canales, J.; Günther Sillero, M.A.; Sillero, A. Diadenosine tetraphosphate activates cytosol 5'-nucleotidase. Biochem. Biophys. Res. Commun., 1986, 138, 261-267.
16. Marques, A.F.; Teixeira, N.A.; Gambaretto, C.; Sillero, A.; Sillero, M.A. IMP-GMP 5'-nucleotidase from rat brain: activation by polyphosphates. J. Neurochem., 1998, 71, 1241-1250.
17. Walldén, K.; Nordlund. P. Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II. J. Mol. Biol., 2011, 408, 684-696.
18. Gasmi, L.; McLennan, A. G.; Edwards, S. W. The diadenosine polyphosphateAp3A and Ap4A and adenosine triphosphate interact with granulocyte-macrophage colony-stimulating factoe to delay neutrophil apoptosis: implications for neutrophil. Platelet interactionsduring inflammation. http://www.ncbi.nlm.nih.gov/pubmed/ 8605363 Blood, 1996, 87, 3442-3449.
19. Baxi, M. D.; McLennan, A. G.; Vishwanatha, J. K. Charactrization of the HeLa cell DNA polymerase alpha-associated Ap4A binding protein by photoaffinity labelling. Biochemistry, 1994, 33, 14601-14607.
20. Kisselev, L.L.; Justesen, J.; Wolfson, A. D.; Frolova, L. Y. Diadenosine oligophosphates (ApnA), a novel class of signalling molecules?, FEBS Lett., 1998, 427, 157-163.
21. Pesi, R.; Micheli, V.; Jacomelli, G.; Peruzzi, L.; Camici, M.; Garcia-Gil, M.; Allegrini, S.; Tozzi, M.G. Cytosolic 5'-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. Neuroreport, 2000, 11, 1827-1831.
22. Li, L.; Schaid D.J.; Fridley, B.L.; Kalari, KR; Jenkins, G.D.; Abo, R.P.; Batzier, A.; Moon, I.; Pelleymounter,L.; Eckloff, B.W.; Wieben, E.D.; Sun, Z.; Yang, P.; and Wang, L. Gemcitabine metabolic pathway genetic polymorphisms and response in non-small cell lung cancer patients. Pharmacogenet. Genomics, 2012, 22, 105-116.
23. Kulkarni, S.S.; Karlsson, H.K.; Szekeres, F.; Chibalin, A.V.; Krook. A.; Zierath, J.R. Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle. J. Biol. Chem., 2011, 286, 34567-34574.
24. Borowiec, A.; Lechward, K.; Tkacz-Stachowska, K. Skladanowski, A. C. Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases. Acta Biochim. Pol., 2006, 53(2), 269-278.
25. Careddu, M.G.; Allegrini, S.; Pesi, R.; Camici, M.; Garcia-Gil, M.; Tozzi, M.G. Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells. Biochim. Biophys. Acta, 2008, 1783, 529-535.
26. Camici, M; Micheli, V; Ipata, P.L.; Tozzi, M. G. Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochemistry Int., 2010, 56, 367-378.
27. Micheli, V; Camici, M; Tozzi, MG; Ipata, PL; Sestini, S; Bertelli, M; Pompucci, G. Neurological Disorders of Purine and Pyrimidine Metabolism. Curr. Top. Med. Chem., 2011, 11, 923-947.
28. Barsotti, C.; Pesi, R.; Felice, F.; Ipata, P.L. The purine nucleoside cycle in cell-free extracts of rat brain: evidence for the occurrence of an inosine and a guanosine cycle with distinct metabolic roles. Cell. Mol. Life Sci., 2003, 60, 786-793.
29. Tozzi, M.G.; Camici, M.; Mascia, L.; Sgarrella, F.; Ipata, P.L. Pentose phosphates in nucleoside interconversion and catabolism. FEBS J., 2006, 273, 1089-1101.
30. Newby, A.C. Adenosine and the concept of "retaliatory metabolites" Trends Biochem. Sci., 1984, 9, 42-44.
31. Schrader, J. Adenosine: a homeostatic metabolite in cardiac energy metabolism. Circulation, 1990, 81, 389-391.
32. Schrader, J.; Baumann, G.; and Gerlach, E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch., 1997, 372, 29-35.
33. Sala-Newby, G.B.; Freeman, N.V.E.; Skladanowski, A.C.; and Newby, A.C. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and-II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines., J. Biol. Chem., 2000, 275, 11666-11671.
34. Sala-Newby, G.B.; Freeman, N.V.E.; Skladanowski, A.C.; Newby, A.C. Metabolic and functional consequences of cytosolic 5'-nucleotidase-IA overexpression in neonatal rat cardiomyocytes, Am. J. Physiol. Heart Circ. Physiol., 2003, 285, H991-H998.
35. Sala-Newby, G.B.; Skladanowski, A.C.; Newby A.C. The mechanism of adenosine formation in cells: cloning of cytosolic 5'-nucleotidase I. J. Biol. Chem., 1999, 274, 17789-17793.
36. Gazziola, C.; Moras, M.; Ferraro, P.; Gallinaro, L.; Verin, R.; Ramazzo, C.; Reichard, P.; Bianchi, V. Induction of human High-Km 5'.Nucleotidase in Cultured 293T cells. Exp. Cell. Res., 1999, 253, 474-482.
37. Rampazzo, C.; Gazziola, C.; Ferraro, P.; Gallinaro, L.; Johansson, M.; Reichard, P.; and Bianchi, V. Human high-Km 5'.Nucleotidase Effects of overexpression of the cloned cDNA in cultured human cells. Eur. J. Biochem., 1999, 261, 689-697.
38. Itoh, R. Purification and some properties of an IMP-specific 5'-nucleotidase from yeast. Biochem. J., 1994, 298, 593-598.
39. Allegrini, S.; Filoni, D.N.; Galli, A.; Collavoli, A.; Pesi, R.; Camici, M.; Tozzi, M.G. Expression of bovine ytosolic 5'-nucleotidase (cN-II) in yeast: nucleotide pools disturbance and its consequences on growth and homologous recombination. Accepted for publication on PlosOne 2013.
40. Hedbacker, K.; Carlson, M. SNF1/AMPK pathways in yeast. Front Biosci., 2008, 13, 2408-2420.
41. Gancedo, J.M. Yeast carbon catabolite repression. Microbiol. Mol. Biol. Rev., 1998, 62, 334-361.
42. Aylon, Y.; Kupiec, M. DSB repair: the yeast paradigm. DNA Repair, 2004, 3, 797-815.
43. Pesi, R.; Allegrini, S.; Golfarini, S.; Baiocchi, C.; Moretti, E.; Camici, M.; Eriksson, S.; and Tozzi, M.G. Identification of multiple forms of the cytosolic 5'-Nucleotidase/phosphotransferase in rat tissues. Adv. Exp. Med. Biol., 1998, 431, 495-499.
44. Garcia-Gil, M.; Bestini, F.; Pesi, R.; Voccoli, V.; Tozzi, M.G.; Camici, M. 5 '-Amino-4-imidazolecarboxamide riboside induces apoptosis in human neuroblastoma cells via the mitochondrial pathway. Nucleosides Nucleotides Nucleic Acids, 2006, 25,1265-1270.
45. Jinnah, H.A.; Friedmann, T. Lesch-Nyhan disease and its variants. In: C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle (Eds) The metabolic and molecular basis of inherited disease, McGraw-Hill, New York, 2000, pp. 2537-2570.
46. Bester, A.C.; Roninger, M.; Oren Y.S.; Im, M.M.; Sarni, D.;Chaoat, M.; Bensimon, A.; Zamir, G.; Shewach, D.S.;Kerem, B. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell, 2011, 145, 435-446.
47. S., Allegrini; R., Pesi; M.G., Tozzi; P.L., Ipata.; Camici, M. Cytosolic 5'-nucleotidase/nucleoside phosphotransferase: a single assay for a bifunctional enzyme., J. Biochem. Biophys. Methods, 1993, 27, 293-299.
48. Pesi, R.; Camici, M.; Micheli, V.; Notarantonio, L.; Jacomelli, G.; Tozzi, M.G. Identification of the nucleotidase responsible for the AMP hydrolysing hyperactivity associated with neurological and developmental disorders. Neurochem. Res., 2008, 33, 59-65.
49. Itoh, R.; Echizen, H.; Higuchi, M.; Oka, J.; Yamada, K. A comparative study on tissue distribution and metabolic adaptation of IMP-GMP 5'-nucleotidase. Comp. Biochem. Physiol., B., 1992, 103, 153-159.
50. Galmarini, C.M.; Graham, K.; Thomas, X.; Calvo, F.; Rousselot, P.; El Jafaari, A.; Cros, E.; Mackey, J.R., Dumontet, C. Expression of high Km 5'.nucleotidase in leukemic blasts is an independent prognostic factor in adults wuth acute myeloid leukemia. Blood, 2001, 98, 1922-1926.
51. Galmarini, C.M.; Thomas, X.; Graham, K.; El Jafaari, A.; Cros, E.; Jordheim, L.; Mackey, J.R.; Dumontet, C. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br. J. Haematol., 2003, 122, 53-60.
52. Tzoneva, G.; Perez-Garcia, A.; Carpenter, Z.; Khiabanian, H.; Tosello, V.; Allegretta, M.; Paietta, E.; Racevskis, J.; Rowe, J.M.; Tallman, M.S.; Paganin, M.; Basso, G.; Hof, J.; Kirschner-Schwabe, R.; Palomero, T.; Rabadan, R.; Ferrando, A. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nat. Med., 2013, 19, 368-371.
53. Galmarini, M.C. What does over-expression of cN-II enzyme signify in haematological malignancies? Leukemia Res., 2007, 34, 1325-1326.
54. Hardie, D.G.; Ross, F.A.; Hawley, S.A. AMP-activated protein kinase: a target for drugs both and modern. Chem. Biol., 2012, 19, 1222-1236.
55. Zaha, V.G.; Young, L.H. AMP-activated protein kinase regulation and biological actions in the heart. Circ. Res., 2012, 111, 800-814.
56. Ramamurthy, S.; Ronnett, G. AMP-Activated Protein Kinase (AMPK) and Energy-Sensing in the Brain. Exp. Neurobiol., 2012, 21, 52-60.
57. Hotta, K.; Kitamoto, A.; Kitamoto, T.; Mizusawa, S.; Teranishi, H.; Matsuo, T.; Nakata, Y.; Hyogo, H.; Ochi, H.; Nakamura, T.; Kamohara, S.; Miyatake, N.;, Kotani, K.; Komatsu, R.; Itoh. N.; Mineo, I.; Wada, J.; Yoneda, M.;Nakajima, A.; Funahashi, T.; Miyazaki, S.; Tokunaga, K.; Masuzaki, H.; Ueno. T.; Chayama, K.; Hamaguchi, K.; Yamada, K.; Hanafusa, T.; Oikawa, S.; Yoshimatsu, H.; Sakata, T.; Tanaka, K.; Matsuzawa, Y.; Nakao, K.; Sekine, A. Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women. J. Hum. Genet., 2012, 57, 46-51.